Pacific Biosciences of California Cash Flow Quality Index
Pacific Biosciences of California cash flow quality index. Pacific Biosciences of California (PACB) has a Cash Flow Quality Index of -12.93x as of December 2024. Operating cash flow of $-30.65 Million is below net income of $2.37 Million, suggesting accrual-heavy earnings not yet converted to cash. See PACB FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pacific Biosciences of California (2020–2020)
Cash flow quality index of Pacific Biosciences of California from 2020 to 2020. Historical Cash Flow Quality Index for Pacific Biosciences of California across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PACB cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Pacific Biosciences of California Cash Flow Quality Index by Year (2020–2020)
Pacific Biosciences of California cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Pacific Biosciences of California. For the full cash flow conversion analysis, see PACB cash generation efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.66x | $19.50 Million | $29.40 Million | — |